Skip to main content
2026 CRT Conference Main banner

CRT 2026

Innovation and Technology

Session:: Medtech Mitral Tricuspid Valve and LAAO Regulatory Science Town Hall [Non-CME]

Panel Discussion | Transcatheter Mitral Valve Therapies | Challenges and Opportunities

Monday, March 9, 2026
3:40 PM - 4:10 PM EST
Location: International Ballroom East

    Moderator(s)

  • Steven F. Bolling, MD

    Professor of Cardiac Surgery
    University of Michigan Hospital
    Ann Arbor, Michigan, United States

    Disclosure information not submitted.

  • Vinayak Bapat, FRCS(CTh)

    Consultant
    Abbott Northwestern Hospital & Minneapolis Heart Foundation
    Minneapolis, Minnesota, United States

    Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing)

  • Changfu Wu, PhD

    SBRBPAS Expert
    Food and Drug Administration
    Silver Spring, Maryland, United States

    Disclosure information not submitted.

    • Panel Discussant(s)

  • Andrew D. Althouse, PhD

    Senior Principal Statistician
    Medtronic

    Disclosure(s): Medtronic, Inc.: Employee (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)

  • Ori Ben-Yehuda, MD

    Professor of Medicine
    University of California, San Diego
    La Jolla, California, United States

    Disclosure information not submitted.

  • Jeff W. Chambers, MD, FSCAI, FACC

    Director of the percutaneous Coronary Interventions
    Metropolitian Heart and Vascular Institute
    Minneapolis, Minnesota, United States

    Disclosure(s): Zoll/Therox: Consulting Fees (e.g., advisory boards) (Ongoing)

  • Mayra E. Guerrero, MD, FACC, FSCAI

    Professor of Medicine
    Mayo Clinic Hospital
    Rochester, Minnesota, United States

    Disclosure(s): No financial relationships to disclose

  • EK

    Elana Koss, MD

    Director
    North Shore University Hospital, Northwell Health

    Disclosure information not submitted.

  • Scott Lim, MD

    Professor of Medicine
    University of British Columbia
    Vancouver, British Columbia, Canada

    Disclosure information not submitted.

  • Kevin G. Soucy, PhD

    Principal Consultant
    CardioMed Device Consultants, LLC, United States

    Disclosure(s): Many cardiovascular device manufacturers: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):
Vinayak Bapat, FRCS(CTh): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing)
Andrew D. Althouse, PhD: Medtronic, Inc.: Employee (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)
Jeff W. Chambers, MD, FSCAI, FACC: Zoll/Therox: Consulting Fees (e.g., advisory boards) (Ongoing)
Mayra E. Guerrero, MD, FACC, FSCAI: No financial relationships to disclose
Kevin G. Soucy, PhD: Many cardiovascular device manufacturers: Consulting Fees (e.g., advisory boards) (Ongoing)